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Plastic bronchitis is a rare disease intractable to medicaltreatment, including steroids. It is characterized by re-current expectoration of peculiar bronchial casts. Plasticbronchitis may be caused by primary bronchopulmonary
disease but may occur in children after surgery for cyanotic con-
genital heart disease,1 especially after the Fontan procedure. Al-
though the etiology of this rare disease remains unknown, the
elevations of central venous pressure (CVP) and disorders of the
lymphatic system are suggested as probable pathogenetic mecha-
nisms for plastic bronchitis, the same as for protein losing enter-
opathy.2 We report here a case of plastic bronchitis after the
Fontan procedure with successful treatment by combined use of
epoprostenol and sildenafil citrate.
Clinical Summary
A 4-year-old boy with hypoplastic left heart syndrome and bilat-
eral superior venae cavae was admitted to our hospital for recur-
rent pneumonia and chronic coughing. He underwent a Norwood
procedure at 14 days old, a bilateral bidirectional Glenn procedure
at 3 months old, and a Fontan procedure at 3 years old. After the
Fontan procedure, he had severe pneumonia, atelectasis, and chy-
lothorax, which necessitated mechanical assisted ventilation for 3
weeks. Two months after the Fontan procedure, a productive
cough, wheezing, and dyspnea developed. A chest x-ray film
revealed diffuse infiltration in the right middle and lower lobes.
Despite treatment with antibiotics, he started to expectorate pecu-
liar bronchial casts (Figure 1), which led to the diagnosis of plastic
bronchitis. Echocardiography demonstrated normal right ventric-
ular systolic and diastolic function with trivial tricuspid regurgi-
tation. There was neither stenosis of the Fontan route nor pleural
effusion. Oral prednisolone (2 mg/kg/d) was given for his plastic
bronchitis, but he resumed expectorating the bronchial casts. Car-
diac catheterization 132 days after the Fontan procedure showed
increased mean CVP and pul-
monary arterial pressure up to
16 mm Hg. The pulmonary
arterial resistance (PAR) was
8.1 Wood units/m2. Cardiac
index calculated by the Fick
method was 2.8 L/min/m2. To
reduce mean CVP with a pulmonary vasodilator, we started a
continuous intravenous infusion of epoprostenol at a starting dose
of 2 ng/kg/min, which was gradually increased to 16 ng/kg/min
over 8 weeks. Although he had no bronchial casts for the initial 3
weeks after administration of epoprostenol, he started to expecto-
rate the bronchial casts again. A repeated cardiac catheterization 3
months after the start of epoprostenol therapy showed improve-
ment in hemodynamic parameters: mean CVP was decreased to 12
mm Hg and PAR to 4.5 Wood units/m2. However, he continued to
produce bronchial casts. Bronchoscopic examination revealed that
the bronchial casts were produced from the right bronchus. After
informed consent had been obtained from his parents, sildenafil
citrate, a selective phosphodiesterase-5= inhibitor, known to be a
very potent pulmonary arterial vasodilator, was added to reduce
PAR further.3,4 The initial dosage of sildenafil citrate was 0.5 mg/
kg/d, and dosage increased to 1.0 mg/kg/d. After the addition of
sildenafil citrate to epoprostenol, no bronchial casts were expecto-
rated. He was able to be weaned from epoprostenol 6 months after
starting sildenafil citrate. No recurrence of the bronchial casts has
been found since then.
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doi:10.1016/j.jtcvs.2006.05.067 Figure 1. Bronchial cast expectorated by this patient.
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Discussion
Bronchial casts have been reported in association with a number of
childhood diseases, including cyanotic congenital heart diseases,
and may cause life-threatening airway obstruction. Seear and as-
sociates5 reported two types of bronchial casts, inflammatory and
acellular, on the basis of histologic findings. In the acellular type,
the casts are composed more of mucin than of fibrin and lack
infiltration of inflammatory cells. This condition is mainly ob-
served in patients who have been operated on for cyanotic heart
disease. On the other hand, inflammatory cellular infiltration, with
neutrophils, lymphocytes, and macrophages, is prominent in the
inflammatory type and may be the result of acute or chronic
inflammation or an allergic reaction in the airway.
The histologic findings of the bronchial casts in our patient
revealed fibrin clusters including monocytes and macrophages,
which suggest the inflammatory type of bronchial cast even though
he had no history of allergic airway disease such as bronchial
asthma (Figure 2). The one explanation for this is that his bronchial
casts appeared only during respiratory infections. Aside from this,
the presence of inflammatory plastic bronchitis in our patient is
very unusual, because most patients with plastic bronchitis after
cardiac surgery have acellular casts.
Treatment of plastic bronchitis is reported to be difficult. In-
haled or oral prednisolone is usually effective for the inflammatory
type of plastic bronchitis. Although oral prednisolone was com-
menced in our case, expectoration of bronchial casts continued and
was resistant to steroid therapy. Then we started continuous intra-
venous infusion of epoprostenol to reduce mean pulmonary arterial
pressure, since high CVP and PAR were considered as probable
causes of plastic bronchitis, especially after the Fontan procedure.
After administration of epoprostenol, expectoration of bronchial
casts stopped once, but then recurred. Therefore, we added silde-
nafil citrate as an additional potent pulmonary vasodilator to fur-
ther reduce CVP and PAR. After the addition of sildenafil citrate,
he stopped expectorating bronchial casts and finally could be
weaned from epoprostenol 6 months after starting sildenafil citrate.
In summary, pulmonary vasodilation therapy with sildenafil
citrate and epoprostenol effectively treated steroid-resistant plastic
bronchitis after the Fontan procedure. The exact mechanism of this
successful pulmonary vasodilation therapy remains unknown, but
from a practical point of view, this combination therapy of silde-
nafil citrate and epoprostenol was clinically very effective for a
patient with plastic bronchitis involving high CVP and PAR after
the Fontan procedure.
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Figure 2. Histologic examination of the cast showing fibrin material
including neutrophils and macrophages.
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